Michael L. Vazquez

837 total citations
21 papers, 537 citations indexed

About

Michael L. Vazquez is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Michael L. Vazquez has authored 21 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Pharmacology and 4 papers in Organic Chemistry. Recurrent topics in Michael L. Vazquez's work include Inflammatory mediators and NSAID effects (7 papers), Estrogen and related hormone effects (3 papers) and Steroid Chemistry and Biochemistry (3 papers). Michael L. Vazquez is often cited by papers focused on Inflammatory mediators and NSAID effects (7 papers), Estrogen and related hormone effects (3 papers) and Steroid Chemistry and Biochemistry (3 papers). Michael L. Vazquez collaborates with scholars based in United States, Italy and Philippines. Michael L. Vazquez's co-authors include Richard B. Silverman, James K. Gierse, Gabriel Mbalaviele, Jeff Carter, William M. Moore, David C. Limburg, Joseph B. Monahan, Jane Wang, Alexander F. Shaffer and Jaime L. Masferrer and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Michael L. Vazquez

21 papers receiving 520 citations

Peers

Michael L. Vazquez
Stan Tsing United States
Marlys Hammond United States
Katsunori Tsuboi Japan
Richard A. Nugent United States
Serdar Kurtkaya United States
Zahra Parandoosh United States
Corinne E. Augelli‐Szafran United States
Robert W. Wiethe United States
Stephen J. Mnich United States
J. Romine United States
Stan Tsing United States
Michael L. Vazquez
Citations per year, relative to Michael L. Vazquez Michael L. Vazquez (= 1×) peers Stan Tsing

Countries citing papers authored by Michael L. Vazquez

Since Specialization
Citations

This map shows the geographic impact of Michael L. Vazquez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Vazquez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Vazquez more than expected).

Fields of papers citing papers by Michael L. Vazquez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael L. Vazquez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Vazquez. The network helps show where Michael L. Vazquez may publish in the future.

Co-authorship network of co-authors of Michael L. Vazquez

This figure shows the co-authorship network connecting the top 25 collaborators of Michael L. Vazquez. A scholar is included among the top collaborators of Michael L. Vazquez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael L. Vazquez. Michael L. Vazquez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alumasa, John N., et al.. (2023). Antibiotic that inhibits trans -translation blocks binding of EF-Tu to tmRNA but not to tRNA. mBio. 14(5). e0146123–e0146123. 6 indexed citations
2.
Schnute, Mark E., John I. Trujillo, Katherine L. Lee, et al.. (2023). Macrocyclic Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonists. ACS Medicinal Chemistry Letters. 14(2). 191–198. 3 indexed citations
3.
Wang, Bu, Brian Juba, Michael L. Vazquez, et al.. (2017). Microfluidic-Enabled Intracellular Delivery of Membrane Impermeable Inhibitors to Study Target Engagement in Human Primary Cells. ACS Chemical Biology. 12(12). 2970–2974. 24 indexed citations
4.
Caspers, Nicole, Seungil Han, Francis Rajamohan, et al.. (2016). Development of a high-throughput crystal structure-determination platform for JAK1 using a novel metal-chelator soaking system. Acta Crystallographica Section F Structural Biology Communications. 72(11). 840–845. 6 indexed citations
5.
Salazar, F. Javier, Michael L. Vazquez, Jaime L. Masferrer, et al.. (2013). Renal effects induced by prolonged mPGES1 inhibition. American Journal of Physiology-Renal Physiology. 306(1). F68–F74. 11 indexed citations
6.
Walker, Daniel P., Natasha M. Kablaoui, Jeffrey A. Scholten, et al.. (2012). Synthesis and biological evaluation of substituted benzoxazoles as inhibitors of mPGES-1: Use of a conformation-based hypothesis to facilitate compound design. Bioorganic & Medicinal Chemistry Letters. 23(4). 1120–1126. 25 indexed citations
7.
Walker, Daniel P., Yvette M. Fobian, John R. Springer, et al.. (2012). Discovery and SAR of PF-4693627, a potent, selective and orally bioavailable mPGES-1 inhibitor for the potential treatment of inflammation. Bioorganic & Medicinal Chemistry Letters. 23(4). 1114–1119. 41 indexed citations
8.
Kablaoui, Natasha M., Snahel Patel, Keith Hoffmaster, et al.. (2012). Novel benzoxazole inhibitors of mPGES-1. Bioorganic & Medicinal Chemistry Letters. 23(3). 907–911. 20 indexed citations
9.
10.
Mbalaviele, Gabriel, Adele M. Pauley, Alexander F. Shaffer, et al.. (2010). Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor. Biochemical Pharmacology. 79(10). 1445–1454. 54 indexed citations
11.
Wang, Jane, David C. Limburg, Jeff Carter, et al.. (2010). Selective inducible microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors derived from an oxicam template. Bioorganic & Medicinal Chemistry Letters. 20(5). 1604–1609. 56 indexed citations
12.
Li, Xing, Ravi G. Kurumbail, Ronald B. Frazier, et al.. (2008). Homo-timeric structural model of human microsomal prostaglandin E synthase-1 and characterization of its substrate/inhibitor binding interactions. Journal of Computer-Aided Molecular Design. 23(1). 13–24. 16 indexed citations
13.
Graneto, Matthew J., Ravi G. Kurumbail, Michael L. Vazquez, et al.. (2007). Synthesis, Crystal Structure, and Activity of Pyrazole-Based Inhibitors of p38 Kinase. Journal of Medicinal Chemistry. 50(23). 5712–5719. 55 indexed citations
14.
D’Alessio, Roberto, Alberto Bargiotti, Maria Gabriella Brasca, et al.. (2005). Benzodipyrazoles: a new class of potent CDK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(5). 1315–1319. 20 indexed citations
15.
Parlow, John J., Michael L. Vazquez, & Daniel L. Flynn. (1998). A mixed resin bed for the quenching and purification of tetrabutylammonium fluoride mediated desilylating reactions. Bioorganic & Medicinal Chemistry Letters. 8(17). 2391–2394. 20 indexed citations
16.
Vazquez, Michael L., Martin L. Bryant, Michael Clare, et al.. (1995). Inhibitors of HIV-1 Protease Containing the Novel and Potent (R)-(Hydroxyethyl)sulfonamide Isostere. Journal of Medicinal Chemistry. 38(4). 581–584. 37 indexed citations
17.
Vazquez, Michael L., Danny J. Garland, Eric T. Sun, et al.. (1992). Characterization of 3-carboxy-5-phosphono-1,2,3,4-tetrahydroisoquinoline (SC-48981), a potent competitive (NMDA) receptor antagonist, in vitro and in vivo. Neuroscience Letters. 135(2). 149–152. 4 indexed citations
18.
Wood, Paul L., Tadimeti S. Rao, Smriti Iyengar, et al.. (1990). A review of the in vitro and in vivo neurochemical characterization of the NMDA/PCP/Glycine/Ion channel receptor macrocomplex. Neurochemical Research. 15(2). 217–230. 54 indexed citations
19.
Silverman, Richard B., et al.. (1985). Inactivation of monoamine oxidase by allylamine does not result in flavin attachment.. Journal of Biological Chemistry. 260(27). 14648–14652. 19 indexed citations
20.
Vazquez, Michael L. & Richard B. Silverman. (1985). Revised mechanism for inactivation of mitochondrial monoamine oxidase by N-cyclopropylbenzylamine. Biochemistry. 24(23). 6538–6543. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stan Tsing Breakdown of academic impact, for papers by Marlys Hammond Breakdown of academic impact, for papers by Katsunori Tsuboi Breakdown of academic impact, for papers by Richard A. Nugent Breakdown of academic impact, for papers by Serdar Kurtkaya Breakdown of academic impact, for papers by Zahra Parandoosh Breakdown of academic impact, for papers by Corinne E. Augelli‐Szafran Breakdown of academic impact, for papers by Robert W. Wiethe Breakdown of academic impact, for papers by Stephen J. Mnich Breakdown of academic impact, for papers by J. Romine
Rankless by CCL
2026